The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBankers Investment Trust Regulatory News (BNKR)

Share Price Information for Bankers Investment Trust (BNKR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 113.40
Bid: 112.80
Ask: 113.00
Change: 0.00 (0.00%)
Spread: 0.20 (0.177%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 113.40
BNKR Live PriceLast checked at -
Bankers Investment Trust is an Investment Trust

aims to achieve capital and dividend growth over the long term

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues review on The Bankers Invst Trust

14 Aug 2023 07:15

RNS Number : 1150J
Bankers Investment Trust PLC
14 August 2023
 

London, UK, 14 August 2023

 

Edison issues review on The Bankers Investment Trust (BNKR)

The Bankers Investment Trust (BNKR) posted an 8.1% net asset value (NAV) per share total return (TR) in H123 (period ending 30 April 2023). Most of its regional sub-portfolios (sleeves) outperformed their benchmarks, highlighting the respective managers' strong stock-selection capabilities. Dividend income across the portfolio was up 10% in H123 and BNKR declared a second interim dividend of 0.62p (with the ytd payout up c 10% y-o-y). Moreover, Alex Crooke (BNKR's lead manager) now expects FY23 dividend growth of at least 7% versus 5% earlier, which he believes should allow BNKR (after high inflation in FY22) to resume its track record of delivering dividend growth ahead of UK inflation.

 

BNKR can be viewed as a 'one-stop shop' for global equity exposure. Its portfolio consists of six geographic sleeves, managed by Janus Henderson Investors' (JHI's) regional specialists. It is an interesting proposition for investors seeking a global equities portfolio that is balanced geographically, large-cap biased and style-neutral, providing both exposure to growth stocks and growing income. We note that Crooke has recently increased the trust's exposure to more defensive businesses, while avoiding the most popular technology stocks. The manager acknowledges the ongoing disruption caused by the implementation of AI, but focuses on more diverse companies that should benefit from the trend, such as Microsoft and Accenture, rather than pure-play AI businesses.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first company in-market 17 years ago, Edison has more than 100 employees and covers every economic sector. Headquartered in London, Edison also has offices in New York, Sydney and Wellington.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Mel Jenner +44 (0)20 3077 5700 Michal Mordel +44 (0)20 3077 5700

investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on: 

LinkedIn www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFFLFFXVLZBBL
Date   Source Headline
3rd May 20245:31 pmRNSTransaction in Own Shares
3rd May 202412:19 pmRNSNet Asset Value(s)
2nd May 202412:16 pmRNSNet Asset Value(s)
1st May 20242:14 pmRNSTotal Voting Rights
1st May 20241:00 pmRNSNet Asset Value(s)
30th Apr 20245:15 pmRNSTransaction in Own Shares
30th Apr 20241:42 pmRNSNet Asset Value(s)
29th Apr 20245:38 pmRNSTransaction in Own Shares
29th Apr 20244:28 pmRNSNet Asset Value(s)
26th Apr 20241:26 pmRNSNet Asset Value(s)
25th Apr 202412:27 pmRNSNet Asset Value(s)
24th Apr 20245:47 pmRNSTransaction in Own Shares
24th Apr 202412:31 pmRNSNet Asset Value(s)
23rd Apr 20245:38 pmRNSTransaction in Own Shares
23rd Apr 20244:11 pmRNSDoc re. Monthly Factsheet as at 31 March 2024
23rd Apr 20243:52 pmRNSSenior Independent Director
23rd Apr 202411:46 amRNSNet Asset Value(s)
22nd Apr 20243:37 pmRNSNet Asset Value(s)
19th Apr 202412:33 pmRNSNet Asset Value(s)
18th Apr 20245:12 pmRNSTransaction in Own Shares
18th Apr 20241:07 pmRNSNet Asset Value(s)
17th Apr 20245:04 pmRNSTransaction in Own Shares
17th Apr 202412:02 pmRNSNet Asset Value(s)
16th Apr 20245:10 pmRNSTransaction in Own Shares
16th Apr 202412:01 pmRNSNet Asset Value(s)
15th Apr 20245:08 pmRNSTransaction in Own Shares
15th Apr 20243:48 pmRNSNet Asset Value(s)
12th Apr 20245:37 pmRNSTransaction in Own Shares
12th Apr 202412:27 pmRNSNet Asset Value(s)
12th Apr 20249:02 amRNSTransaction in Own Shares
11th Apr 202412:06 pmRNSDirector/PDMR Shareholding
11th Apr 202411:56 amRNSNet Asset Value(s)
10th Apr 20245:30 pmRNSTransaction in Own Shares
10th Apr 202412:59 pmRNSNet Asset Value(s)
9th Apr 20245:23 pmRNSTransaction in Own Shares
9th Apr 202412:58 pmRNSNet Asset Value(s)
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20242:23 pmRNSNet Asset Value(s)
5th Apr 20241:27 pmRNSNet Asset Value(s)
4th Apr 20245:21 pmRNSTransaction in Own Shares
4th Apr 202411:56 amRNSNet Asset Value(s)
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20246:29 pmRNSDirector/PDMR Shareholding
3rd Apr 202412:36 pmRNSNet Asset Value(s)
3rd Apr 202411:25 amRNSDirector/PDMR Shareholding
2nd Apr 20245:17 pmRNSTransaction in Own Shares
2nd Apr 20244:09 pmRNSNet Asset Value(s)
2nd Apr 202411:11 amRNSTotal Voting Rights
28th Mar 20245:16 pmRNSTransaction in Own Shares
28th Mar 20242:52 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.